The ability of FGF21 to ameliorate signs of non-alcoholic fatty liver disease in mice depends on sex and diet.
- 1Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Abstract
Consumption of high-calorie food leads to the development of obesity and non-alcoholic fatty liver disease (NAFLD). The pathogenesis of NAFLD depends on the composition of the diet. Administration of fibroblast growth factor 21 (FGF21) to obese mice improves metabolism and liver condition; however, the dependence of this effect on sex and diet composition has not been studied. Objective: To investigate the influence of sex on liver condition in mice with diet-induced obesity caused by different diets and on the ability of FGF21 to beneficially affect liver function. Obesity was induced in male and female C57BL/6J mice using a high-fat diet (HFD) or a cafeteria diet (DCaf). After obesity development, mice were administered FGF21 (1 mg/kg for 7 days), and the morphofunctional state and gene expression in the liver were assessed. When maintained on an HFD, hepatic steatosis was less severe in females than in males. FGF21 did not affect the lipid droplet area in individuals of either sex but exerted a sex-dependent influence on gene expression: in females, it reduced the expression of glycolysis and lipogenesis genes, preventing lipid accumulation, while in males, it reduced the expression of inflammation, apoptosis, and fibrosis genes, preventing the transition from steatosis to steatohepatitis. When maintained on a DCaf, pronounced steatosis developed in mice of both sexes. FGF21 reduced liver lipid content regardless of sex. However, only in females did FGF21 reduce the expression of the Cidec gene involved in lipid droplet formation and increase the number of apoptotic bodies. In males, the effect of FGF21 on lipid accumulation in the liver appeared to be mediated by its action on other tissues. Thus, in obese mice, sex differences in the severity of hepatic steatosis depended on the diet type and were observed only against the background of HFD. Administration of FGF21 led to a reduction in the total area of lipid droplets in the liver in mice of both sexes only against the background of pronounced steatosis induced by the DCaf. The influence of FGF21 on gene expression in the liver was sex-dependent, both against the background of HFD and DCaf.
Related
- The ability of SAMHD1-deficient monocytes to trigger the Type I IFN response depends on cGAS and mitochondrial DNA
- Targeting FGF23 to Ameliorate Anemia in Chronic Kidney Disease
- A nested case-control study on the relationship between gut microbiota and non-alcoholic fatty liver disease
- Alpha-Lipoic Acid and Saxagliptin Attenuate Ferroptosis-Related Ovarian Injury and Modulate FGF21/NOX4–NRF2/HO-1 Signaling in Letrozole-Induced Polycystic Ovary Syndrome
- Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging.
BibTeX
@article{balybina2026ability,
title = {{The ability of FGF21 to ameliorate signs of non-alcoholic fatty liver disease in mice depends on sex and diet.}},
author = {N Yu Balybina and E N Makarova and T V Jakovleva and A Yu Kazantseva and N M Bazhan},
journal = {Vavilovskii zhurnal genetiki i selektsii},
year = {2026},
month = oct,
doi = {10.18699/vjgb-26-88},
url = {https://europepmc.org/article/MED/42903659},
note = {CC BY},
}
RIS
TY - JOUR
TI - The ability of FGF21 to ameliorate signs of non-alcoholic fatty liver disease in mice depends on sex and diet.
AU - N Yu Balybina
AU - E N Makarova
AU - T V Jakovleva
AU - A Yu Kazantseva
AU - N M Bazhan
PY - 2026
DA - 2026/10/01
JO - Vavilovskii zhurnal genetiki i selektsii
DO - 10.18699/vjgb-26-88
UR - https://europepmc.org/article/MED/42903659
AB - Consumption of high-calorie food leads to the development of obesity and non-alcoholic fatty liver disease (NAFLD). The pathogenesis of NAFLD depends on the composition of the diet. Administration of fibroblast growth factor 21 (FGF21) to obese mice improves metabolism and liver condition; however, the dependence of this effect on sex and diet composition has not been studied. Objective: To investigate the influence of sex on liver condition in mice with diet-induced obesity caused by different diets and on the ability of FGF21 to beneficially affect liver function. Obesity was induced in male and female C57BL/6J mice using a high-fat diet (HFD) or a cafeteria diet (DCaf). After obesity development, mice were administered FGF21 (1 mg/kg for 7 days), and the morphofunctional state and gene expression in the liver were assessed. When maintained on an HFD, hepatic steatosis was less severe in females than in males. FGF21 did not affect the lipid droplet area in individuals of either sex but exerted a sex-dependent influence on gene expression: in females, it reduced the expression of glycolysis and lipogenesis genes, preventing lipid accumulation, while in males, it reduced the expression of inflammation, apoptosis, and fibrosis genes, preventing the transition from steatosis to steatohepatitis. When maintained on a DCaf, pronounced steatosis developed in mice of both sexes. FGF21 reduced liver lipid content regardless of sex. However, only in females did FGF21 reduce the expression of the Cidec gene involved in lipid droplet formation and increase the number of apoptotic bodies. In males, the effect of FGF21 on lipid accumulation in the liver appeared to be mediated by its action on other tissues. Thus, in obese mice, sex differences in the severity of hepatic steatosis depended on the diet type and were observed only against the background of HFD. Administration of FGF21 led to a reduction in the total area of lipid droplets in the liver in mice of both sexes only against the background of pronounced steatosis induced by the DCaf. The influence of FGF21 on gene expression in the liver was sex-dependent, both against the background of HFD and DCaf.
SN - 2500-0462
SN - 2500-3259
ER -